financetom
Business
financetom
/
Business
/
Axis Bank likely to own up to 20% stake in Max Life; deal likely at book value
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Axis Bank likely to own up to 20% stake in Max Life; deal likely at book value
Feb 25, 2020 6:02 AM

Axis Bank, which recently announced entering into a strategic partnership with Max Financial for a deal in Max Life Insurance, is looking to buy an additional 17.9 percent stake in Max Life, sources with direct knowledge shared with CNBC-TV18.

Axis Bank is likely to pay around Rs 550 crore to Max Financial for the stake and own a total 19.9 percent stake in Max Life as it currently owns 2 percent, two independent sources indicated. The transaction will include an extension of the long-term insurance tie-up agreement with Axis Bank. Banking regulator, RBI’s approval is required for Axis Bank to buy additional stake in Max Life.

Sources suggest that the deal will be done at the book value of Max Life which is currently at Rs 3,050 crore. Max Financial Services currently owns 72.5 percent stake in Max Life and post the deal is likely to be reduced to 54.5 percent. Mitsui Sumitomo Insurance currently holds a 25.5 percent stake in Max Life.

The boards of both Max Financial Services and Max Life had approved a stake sale to Axis Bank on Feb 20, 2020. Notification to the exchanges said, “Axis Bank Limited and Max Financial Services Limited have entered into a confidentiality and exclusivity arrangement to explore a long-term strategic partnership” Axis Bank & Max Financial Services have signed a 90-day exclusivity agreement for the transaction.

Axis Bank spokesperson responded to CNBC-TV18’s query and said, “Axis Bank does not comment on market speculations.” Max Financial said, “We are under a confidentiality agreement. Hence we are not in a position to comment.”

The stock price of Max Financial gained on the back of the deal announcement. Nomura brokerage report said, “Agreement should address investor concerns on long-term distribution tie-up; maintain buy” it raised the target price for Max Financial Services to Rs 700/share. The deal is positive because Max Life’s bancassurance arrangement with Axis Bank contributes 54 percent to its business and was up for review in September 2021.

First Published:Feb 25, 2020 3:02 PM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
AMC Networks Q3 revenue beats expectations as price hikes drive streaming business
AMC Networks Q3 revenue beats expectations as price hikes drive streaming business
Nov 7, 2025
Overview * AMC Networks ( AMCX ) Q3 revenue declines 6% yr/yr but beats analyst expectations * Adjusted EPS for Q3 misses analyst estimates * Adjusted operating income for Q3 beats analyst expectations * Company highlights growth in streaming revenue and strategic partnerships Outlook * AMC Networks ( AMCX ) expects full-year free cash flow of $250 mln * Streaming...
Oilwell construction services provider McCoy Global Q3 revenue down 6% on deferred shipments
Oilwell construction services provider McCoy Global Q3 revenue down 6% on deferred shipments
Nov 7, 2025
Overview * McCoy Q3 revenue fell 6% yr/yr due to deferred shipments * Net earnings for Q3 rose 7% yr/yr despite revenue decline * Adjusted EBITDA for Q3 decreased 24% yr/yr due to shipment deferrals Outlook * McCoy expects smartProduct demand to grow in MENA region despite market headwinds * Company anticipates TRS contract awards in Eastern Hemisphere in Q1...
Prime Medicine Q3 net loss narrows
Prime Medicine Q3 net loss narrows
Nov 7, 2025
Overview * Prime Medicine ( PRME ) Q3 net loss narrows to $50.6 mln from $52.5 mln last year * Operating expenses rise due to increased R&D costs, offset by lower G&A expenses * Company advances liver-targeted programs, clinical data expected in 2027 Outlook * Prime Medicine expects to file IND/CTA for WD in H1 2027 * Initial clinical data...
Enbridge Q3 profit misses expectations, reaffirms 2025 guidance
Enbridge Q3 profit misses expectations, reaffirms 2025 guidance
Nov 7, 2025
Overview * Enbridge ( ENB ) Q3 adjusted EPS misses analyst expectations, reflecting higher financing costs * Company reaffirms 2025 financial guidance and multi-year financial outlook * Enbridge ( ENB ) announces C$3 bln in sanctioned projects, including Southern Illinois Connector Outlook * Enbridge ( ENB ) reaffirms 2025 adjusted EBITDA guidance of C$19.4 bln to C$20.0 bln * Company...
Copyright 2023-2026 - www.financetom.com All Rights Reserved